Celularity Inc — Director's Dealing 2022

Jul 16, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celularity Inc (CELU)
CIK: 0001752828
Period of Report: 2022-07-13

Reporting Person: Glover Bradley (Director, Chief Technology Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-07-13	Class A Common Stock	A	13124	$0.00	Acquired	32810	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-07-13	Stock Option (Right to Buy)	$10.16	A	38481	Acquired	2032-07-13	Class A Common Stock (38481)	Direct

Footnotes

F1: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

F2: This option was granted under the 2021 Plan and shall vest and become exercisable over a four-year period, with 25% of the option vesting on April 13, 2023, and the remainder vesting in equal monthly installments thereafter so that vested in full on April 13, 2026, and subject to the Reporting Person's continuous service on each vesting date.